High-dose ibuprofen—updated advice ● Risk management of new insulin products ● Mindfulness-based cognitive therapy ● Revised recommendations on administering live vaccines ● GI bleeding risk with dabigatran and ▼rivaroxaban ● Digoxin linked to increased mortality risk? ● More on faecal microbiota transplantation ● Review of treatments for hirsutism ● MHRA restricts use of hydroxyzine
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.